PubMed=3472019; DOI=10.1016/0145-2126(87)90082-8
Kees U.R., Ford J., Price P.J., Meyer B.F., Herrmann R.P.
PER-117: a new human ALL cell line with an immature thymic phenotype.
Leuk. Res. 11:489-498(1987)

PubMed=7541097
Kees U.R., Ashman L.K.
Synergistic action of interleukin-2 and Steel factor (SLF) on a human T lymphoblastoid cell line.
Leukemia 9:1046-1050(1995)

PubMed=10556553; DOI=10.1016/S0022-1759(99)00088-5
Mordvinov V.A., Peroni S.E., De Boer M.L., Kees U.R., Sanderson C.J.
A human T-cell line with inducible production of interleukins 5 and 4. A model for studies of gene expression.
J. Immunol. Methods 228:163-168(1999)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

PubMed=12883040
Kees U.R., Ford J., Watson M., Murch A.R., Ringner M., Walker R.L., Meltzer P.S.
Gene expression profiles in a panel of childhood leukemia cell lines mirror critical features of the disease.
Mol. Cancer Ther. 2:671-677(2003)

PubMed=17117183; DOI=10.1038/sj.bjc.6603447; PMCID=PMC2360743
Beesley A.H., Palmer M.-L., Ford J., Weller R.E., Cummings A.J., Freitas J.R., Firth M.J., Perera K.U., de Klerk N.H., Kees U.R.
Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines.
Br. J. Cancer 95:1537-1544(2006)